[go: up one dir, main page]

MY199933A - Compositions and methods for immunooncology - Google Patents

Compositions and methods for immunooncology

Info

Publication number
MY199933A
MY199933A MYPI2018702099A MYPI2018702099A MY199933A MY 199933 A MY199933 A MY 199933A MY PI2018702099 A MYPI2018702099 A MY PI2018702099A MY PI2018702099 A MYPI2018702099 A MY PI2018702099A MY 199933 A MY199933 A MY 199933A
Authority
MY
Malaysia
Prior art keywords
immunooncology
methods
compositions
reagents
directed
Prior art date
Application number
MYPI2018702099A
Inventor
Ming-Wei Chen
Melissa Deck
Glenn Dranoff
Craig Mickanin
Reynald Lescarbeau
Celeste Richardson
Morag Stewart
Yi Yang
Original Assignee
Novartis Ag
Intellia Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Intellia Therapeutics Inc filed Critical Novartis Ag
Priority claimed from PCT/IB2016/057318 external-priority patent/WO2017093969A1/en
Publication of MY199933A publication Critical patent/MY199933A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is directed to genome editing systems, reagents and methods for immunooncology.
MYPI2018702099A 2015-12-04 2016-12-02 Compositions and methods for immunooncology MY199933A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562263169P 2015-12-04 2015-12-04
US201662136784P 2016-04-01 2016-04-01
US201662394290P 2016-09-14 2016-09-14
PCT/IB2016/057318 WO2017093969A1 (en) 2015-12-04 2016-12-02 Compositions and methods for immunooncology

Publications (1)

Publication Number Publication Date
MY199933A true MY199933A (en) 2023-11-29

Family

ID=94538273

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018702099A MY199933A (en) 2015-12-04 2016-12-02 Compositions and methods for immunooncology

Country Status (1)

Country Link
MY (1) MY199933A (en)

Similar Documents

Publication Publication Date Title
MX2025006476A (en) Compositions and methods for immunooncology
PH12019502171A1 (en) Composition and methods for immunooncology
PH12018501378A1 (en) Compositions and methods for the treatment of hemoglobinopathies
PH12019501812A1 (en) Compositions and methods for the treatment of hemoglobinopathies
MX2020005213A (en) Mk2 inhibitors and uses thereof.
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
PH12016501763A1 (en) Multispecific antibodies
MX2015008999A (en) Mk2 inhibitors and uses thereof.
MX2016003843A (en) Irak inhibitors and uses thereof.
MX2018005292A (en) Acc inhibitors and uses thereof.
MX2018016038A (en) Compounds and methods for modulating rna function.
MX2016000997A (en) Methods and compositions for detecting bacterial contamination.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2018004674A (en) Modulators of sestrin-gator2 interaction and uses thereof.
MX2018000715A (en) Methods for treating cancer using apilimod.
PH12017501864A1 (en) Compositions and methods for treating autism
MX2020007742A (en) Processes for preparing fluoroketolides.
MX2023009431A (en) Method of making a mercury based compound, mercury based compound, methods of using the mercury based compound and uses of the mercury based compound.
EA201692246A1 (en) Method of producing 2,6-dimethylbenzoquinone
MY199933A (en) Compositions and methods for immunooncology
AU366435S (en) Dry pipe
UA99992U (en) 2,34-tetrahydropyridin-6-thiolate
IN2013CH00453A (en)
UA94338U (en) 2-oxo-5-phenyl-2,3-dihydro-thiazole[4,5-b]pyridine-7-carboxyl acid which reveals anti-exudate effect.